Industry / India
Why Is Eisai In Vizag?
June 2010 | Industry Trend AnalysisLike other Japanese pharmaceutical companies, Eisai is conservative in nature and outlook. The Tokyo-based firm generates the majority of revenue in its domestic market and the US. Its exposure in Europe is limited and emerging markets are currently a low priority.
To read the full article, please choose one of the following options:
Subcribers please log in




